Ibrutinib Impurity 19 | CAS 2031255-25-9 - Request Quote
Ibrutinib Impurity 19
| SZ CAT No: | SZ-I005038 |
| CAS No | 2031255-25-9 |
| Mol.F. | C25H24N6O3 |
| Mol.Wt. | 456.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ibrutinib Impurity 19 is chemically 1-((R)-1-Acryloylpiperidin-3-yl)-4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidine 1-oxide. Ibrutinib Impurity 19 is supplied with detailed characterization data compliant with regulatory guideline. Ibrutinib Impurity 19 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ibrutinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2031255-25-9
Purchase 2031255-25-9
Order 2031255-25-9
Enquire 2031255-25-9
price of 2031255-25-9
2031255-25-9 Supplier
2031255-25-9 Manufacturer
2031255-25-9 Exporter
buy high quality Ibrutinib Impurity 19
Purchase Ibrutinib Impurity 19
Ibrutinib Impurity 19 suppliers
Ibrutinib Impurity 19 manufacturers
Ibrutinib Impurity 19 price
Order Ibrutinib Impurity 19
Enquire Ibrutinib Impurity 19
Ibrutinib Impurity 19 cost
Ibrutinib Impurity 19 Supplier
Ibrutinib Impurity 19 Distributor
Ibrutinib Impurity 19 for Method Validation
Ibrutinib Reference Standard
Ibrutinib Impurity 19 for ANDA Filing
Ibrutinib Impurity 19 for Forced Degradation Studies
Ibrutinib Impurity 19 Identification Standards
Ibrutinib Impurity 19 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.